Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'- dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus

1997-06-30

F E B S Letters , Volume 410 - Issue 2-3 p. 324- 328

Additional Metadata
Keywords	AIDS, HBV, Hepatitis, HIV, Nucleoside analogues, Prodrugs, Reverse transcriptase
Persistent URL	doi.org/10.1016/S0014-5793(97)00616-9, hdl.handle.net/1765/67182
Journal	F E B S Letters
Organisation	Department of Virology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Balzarini, J., Kruining, J., Wedgwood, O., Pannecouque, C., Aquaro, S., Perno, C., … McGuigan, F. E. (1997). Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'- dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. F E B S Letters, 410(2-3), 324–328. doi:10.1016/S0014-5793(97)00616-9

Publication